| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) before income taxes | 147,164 | 99,549 | 20,900 | -98,304 |
| Income tax expense | 22,323 | 5,229 | 19,630 | 23,046 |
| Net income (loss) | 124,841 | 94,320 | 1,270 | -121,350 |
| Basic (in dollars per share) | 0.09 | 0.07 | 0 | -0.09 |
| Diluted (in dollars per share) | 0.08 | 0.06 | 0 | -0.09 |
| Weighted-average shares outstanding diluted (in shares) | 1,488,750,354 | 1,463,277,401 | 1,445,253,219 | 1,376,751,873 |
| Weighted-average shares outstandingbasic (in shares) | 1,432,801,699 | 1,408,166,754 | 1,390,052,966 | 1,376,751,873 |
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)